Product Information

BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE is a generic product labeled by Lannett Company Inc., priced at $0.9687 per EA under NDC 00527155201. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Oct 11, 1985. Its Orange Book therapeutic-equivalence code is AA.

BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE

Butalbital, aspirin, and caffeine
$0.9687per EA
DEA Schedule CIII

Strength

325; 50; 40 mg/1; mg/1; mg/1

NDC

00527155201

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA086996

FDA Approved

10/11/1985

TE Code

AA

On Market Since

10/11/1985

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Barbiturate
Barbiturates
Central Nervous System Stimulant
Central Nervous System Stimulation
Cyclooxygenase Inhibitors
Decreased Platelet Aggregation
Decreased Prostaglandin Production
Methylxanthine
Nonsteroidal Anti-inflammatory Drug
Platelet Aggregation Inhibitor
Xanthines

Price Statistics

The NADAC for BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 81.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.9687 per EA
All-time high$1.0596 (Sep 14, 2016)
All-time low$0.3623 (Nov 20, 2024)
52-week high$1.0486
52-week low$0.9687
Median price$0.9669
Average price$0.9162
Largest weekly change+59.7% (Dec 18, 2024)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

-0.4%

1M

-0.4%

3M

-1.0%

6M

-1.7%

1Y

-7.6%

3Y

+30.7%

5Y

-0.9%

All

+81.2%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE, manufactured by Lannett Company Inc., is $0.9687 per EA (NDC 00527155201), effective Aug 19, 2026.

How has the price of BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE has risen 81.2%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE?

Since Nov 28, 2013, the NADAC for BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE has ranged from a low of $0.3623 (Nov 20, 2024) to a high of $1.0596 (Sep 14, 2016), with a median of $0.9669 per EA.

Are there cheaper alternatives to BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE?

BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE (NDC 00527155201) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.